HAEGTFTSD is a 9-residue peptide of human GLP-1 peptide or GLP-1(7-36), amide (HY-P0054A). GLP-1(7-36), amide is a physiological incretin hormone that stimulates insulin secretionin a glucose-dependant manner^[1]

The GLP-1 (7-36) amide is a product of the preproglucagon gene, which is secreted from intestinal L-cells, in response to the ingestion of food. GLP-1 exerts multiple actions by stimulating insulin secretion from pancreatic β-cells, in a glucose dependent manner (insulinotropic action). GLP-1 lowers circulating plasma glucagon concentration, by inhibiting its secretion (production) from α-cells. GLP-1 also exhibits properties like stimulation of β-cell growth, appetite suppression, delays gastric emptying and stimulation of insulin sensitivity^[1]. The peptide analogs of GLP-1 are useful as glucagon-like peptide 1 receptor agonists^[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

963.94

C₄₀H₅₇N₁₁O₁₇

926018-45-3

HAEGTFTSD

Room temperature in continental US; may vary elsewhere.

Protect from light

*In solvent : -80deg;C, 6 months; -20deg;C, 1 month (protect from light)

• [1]. K Hupe-Sodmann, et al. Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides. Regul Pept. 1995 Aug 22;58(3):149-56.